Advertisement

BMC Cardiovascular Disorders

, 18:238 | Cite as

Incomplete intestinal obstruction as the possible main complaint in Behcet’s disease after surgery for recurrent abdominal aortic pseudoaneurysms: a case report and literature review

  • Fang Jiang
  • Hui Xiang
  • Zhi-Yong PengEmail author
Open Access
Case report
  • 189 Downloads
Part of the following topical collections:
  1. Non-coronary artery cardiac disease

Abstract

Background

Behcet’s disease (BD) is a systemic vasculitis characterized by oral and genital aphthosis, and ocular and skin lesions. The disease is involved in vascular, gastrointestinal, and central nervous systems. Vasculitis may exacerbate fatal problems, such as anastomotic pseudoaneurysms. If the mesenteric vessels are involved, severe abdominal symptoms such as intestinal obstruction may occur.

Case presentation

This case report describes a young female patient who suffered from BD with recurrent abdominal aortic pseudoaneurysms, as well as deep venous thrombosis and subsequent complications of incomplete intestinal obstruction. This patient first underwent stent grafting, which was followed by rupture of two newly formed anastomotic pseudoaneurysms within six months. Emergency open surgical repair (OSR) was then performed on the ruptured pseudoaneurysms. Thrombosis and incomplete ileus occurred five months after surgery. This case was unique due to the presence of incomplete intestinal obstruction being the possible main complaint for a patient with Behcet’s disease, and it is the first ever case to be reported.

Conclusion

Intestinal obstruction may present as the possible main complaint in BD. Careful and attentive strategy should be carried out to prevent fatal outcomes.

Keywords

Behcet’s disease Recurrent abdominal aortic pseudoaneurysm Incomplete intestinal obstruction 

Abbreviations

BD

Behcet’s disease

CT

Computed tomography

CTA

Computed tomographic angiogram

ICU

Intensive care unit

NO

Nitric oxide

OSR

Open surgical repair

Background

Behcet’s disease (BD) is a disease that involves complex multisystem disorders. However, the exact physiopathologic mechanism of BD remains unclear. Evidence shows that arterial and venous systems are involved in BD. Involvement of the venous systems results in the occurrence of thrombosis and superficial phlebitis. Involvement of the arterial systems result in aneurysm or pseudoaneurysm, stenosis, and occlusion [1]. The pseudoaneurysm, which evolves quickly, is prone to rupture and can become life-threatening. Therefore, it is crucial to diagnose and manipulate this fatal condition early. If the mesenteric vessels are involved, severe abdominal symptoms such as intestinal obstruction may occur [2]. However, such symptoms, especially those presenting as the main complaint, are easily misdiagnosed. Here, we report a rare case of a patient who presented with incomplete intestinal obstruction as the possible main complaint after a second surgery. We believe that an examination of this case will help the field make progress toward developing a common procedural strategy for treating such rare conditions.

Case presentation

A 28-year-old female Chinese patient presented with the onset of acute continuous right abdomen pain, nausea and vomiting at the emergency department. On admission, abdominal dynamic computed tomography (CT) with a multislice detector row CT scanner showed several air-fluid levels in the enteric cavity, and the diagnosis was considered to be ileus.

The patient was diagnosed with BD four years ago. She had received medications regularly, including immunosuppressive therapy with oral prednisone (60 mg/day) and cyclophosphamide (100 mg/day).

The patient first presented with abdominal pain at the hospital. A computed tomographic angiography (CTA) was performed, which (Fig. 1) indicated an aneurysm of 5.67 cm*5.28 cm*0.97 cm located in the left junction of the thoracic aorta and abdominal aorta. An approximately 0.8 cm segment was found to block the starting part of the celiac trunk. Subsequently, a graft stent was implanted. Follow-up CTA (Fig. 2) showed no residual aneurysm. However, six months after the intervention, a rapidly growing mass was found in the lower abdomen, and the patient presented with nausea, vomiting, progressive and intermittent pain in the abdomen which radiated to her back. Before being admitted to the intensive care unit (ICU), the patient underwent CTA, which showed that there was a haematoma of approximately 6.0 × 4.8 cm in the abdomen. The extravasation of contrast agent was located in the opening of the renal artery, with a mixed soft tissue mass of 3.7 cm (Fig. 3) in the haemoperitoneum. The haemoglobin concentration decreased to 4.36 g/dL with abrupt hypotension (60/43 mmHg). The critical condition of the patient prompted the cardiac surgeons to perform open surgical repair (OSR) rather than a more conservative treatment. The patient was transferred to the ICU after the operation. Three days later, after her vital signs were stable, she was transferred back to the general ward. No recurrence of pseudoaneurysm was found during a follow-up of 15 days (Fig. 4). She continued receiving immunosuppressive therapy as usual. This course of treatment was decided based on previous studies showing that use of immunosuppressive therapy with cyclophosphamide and corticosteroids before and after surgical intervention could help prevent BD activation [3, 4].
Fig. 1

The aneurysm prior to intervention. A1:The aneurysm was located in the left junction of the thoracic and abdominal aorta. A2: The size of aneurysm was 5.67 cm*5.28 cm*0.97 cm. A3: The segmental block of the starting part of the celiac trunk was approximately 0.8 cm. Arrow pointed to the aneurysm

Fig. 2

The aneurysm after intervention (B1, B2). The upper end was located in the cardia level, and the lower end in the upper edge of the superior mesenteric artery opening. Arrow pointed to the stent implantation site

Fig. 3

The hematoncus occured at 6 months after intervention. The size was 6.0*4.8 cm. The extravasation of contrast agent located in the opening of the renal artery, and the thickness of this mixed soft tissue mass was 3.7 cm

Fig. 4

Implantation of artificial vascular in the thoracic and abdominal aorta. Two transplanted vessels were seen in picture D, one of which was connected to abdominal aorta, the other connected to right common iliac artery

Ten months later, after the implantation of artificial vascularization in the thoracic and abdominal aorta, doppler-ultrasound indicated deep venous thrombosis in the left popliteal vein (Fig. 5). Therefore, the patient was treated with anticoagulant therapy using hypodermic injections of low-molecular-weight heparin at a daily dose of 4100 U.
Fig. 5

The deep venous thrombosis in the left popliteal vein. It was detected by doppler-ultrasound. Arrow pointed to the thrombosis

One month later, the patient suffered from persistent right abdominal pain with nausea and vomiting accompanied by oral aphtha and genital ulcer. Abdominal CT showed the occurrence of an air-fluid level in part of the ileum and colon (Fig. 6). The diagnosis was determined to be an incomplete intestinal obstruction, which may have been caused by the previous aneurysms. Mesenteric artery angiography showed that the root of the celiac trunk and superior mesenteric artery were stenosed (Fig. 7). Then, conservative treatment was administered, such as fasting, gastrointestinal decompression and enema. Approximately 20 days later, the patient recovered well and was discharged from the hospital.
Fig. 6

Air-fluid level (arrows). Detected by abdominal computed tomography

Fig. 7

The root stenosis of celiac trunk and superior mesenteric artery. Detected by mesenteric artery angiography

Discussion and conclusions

Here we demonstrated a case of a patient with a diagnosis of BD who presented with incomplete intestinal obstruction as the possible main complaint. To the best of our knowledge, this is the first report of the presence of incomplete intestinal obstruction after a second surgery for BD.

Recent studies have reported that HLA-B51 is associated with a more severe disease and is related to familial BD [5]. Other studies have shown that polymorphism in the IL-21, IL-10, and IL-8 genes and in the tumour necrosis factor-(TNF-)alpha-1031C allele are correlated with the pathogenesis of BD [6, 7, 8, 9, 10, 11]. The role of the IL-23/IL-17 axis has been found to be associated with the onset of BD [12, 13]. Meanwhile, delayed-type hypersensitivity to infections such as streptococcus species (especially sanguis) has also been proposed to be an important factor in inducing BD [14]. Hematological diseases such as coagulation abnormalities and platelet overactivity may play additional roles in the development of BD [15, 16, 17]. Nitric oxide (NO) accumulation after induction by interferon-gamma is also related to the activation of BD [18].

BD can be divided into two categories according to the pathological mechanism: occlusive and lesion. Although venous involvement is the most common vasculo-BD complication, Ketari et al. has been reported that arterial involvement is more common than venous involvement [19]. The most severe complication is aneurysm formation and rupture. Approximately 60% of reported arterial lesions associated with BD are aneurysms [20]. The aorta is the most commonly affected artery followed by the pulmonary artery. Aneurysms occur more frequently in the abdominal aorta than in the thoracic aorta [21, 22, 23].

Surgical repair is the standard treatment for aneurysms with dilatation, stenosis, or obstruction, while alternative treatments involve minimally invasive endovascular therapy for aneurysm repair [22, 24, 25]. Shen et al. reported that both open surgery and endovascular repair were safe and effective for treating aortic pseudoaneurysm in BD [26]. Furthermore, Naganuma et al. reported that ulcer lesions in the ileum and colon, which could lead to intestinal obstruction, were found in surgical patients with intestinal BD [27].

In our report, it was challenging to diagnose the patient who presented with initial symptoms of abdominal pain and vomiting. The differential diagnoses included pseudoaneurysm, ileus, new recurrent arterial aneurysm, mesenteric arterial embolism and so on. To obtain an accurate diagnosis, abdominal computed tomography and angiography were performed. CT/CTA results showed that the patient suffered from intestinal obstruction. The cause may be related to chronic vascular lesions, which could finally lead to an insufficient blood supply in the mesenteric artery. Literature review demonstrated that intestinal obstruction presented with BD in three cases. Of them, two cases of BD that presented with abdominal aortic aneurysm were diagnosed with ileus after stent graft interposition [28]. One patient with BD suffered from complete obstruction 6 years after several operations. The operations included an aortobifemoral bypass grafting for an abdominal aortic aneurysm [2] (Table 1). However, incomplete intestine obstruction was not reported as the main complaint for these patients. Our case report is the first to present incomplete intestinal obstruction as the possible main complaint of BD. Unfortunately, there are no certain guidelines for how to prevent and treat intestinal obstruction caused by BD. Thus, prompt differential diagnosis and management are essential for future treatment.
Table 1

Characteristics of lesion, treatment and outcome for patients complicated with intestinal obstruction from literature review

Patient

Location

symptom

Treatment (graft size: mm & type)

Complication

Immuno-suppresant

Recurrence

Follow up

Result

38 yrs. male

Infrarenal

C. Rupture

Interposition (Polytetrafluoroethylene) 16 × 8, bifurcated

Incomplete Intestinal Obstruction

Prednisolone + Colchicines

None

98 M

Alive

31 yrs. male

Suprarenal

Rupture

Patch (Polytetrafluoroethylene)

Incomplete Intestinal Obstruction

Colchicines + Azathioprine

18 M

43 M

Alive

50 yrs. male

Suprarenal

vascular thrombosis

Stent graft

Complete Intestinal Obstruction

Not clear

72 M

5 M

Alive

Considering the paucity of data available, the management of patients with intestinal obstruction should be individualized, and a multidisciplinary approach should be taken. Differential diagnosis and management are essential when addressing this fatal problem.

Technologies such as abdominal computed tomography and angiography are recommended resources when determining differential diagnosis. Finally, if intestinal obstruction is confirmed with the diagnosis, appropriate measures (surgical or nonsurgical treatment) to treat this disease should be taken.

Notes

Acknowledgements

We would like to express our sincere appreciation to Dr. Jinping Zhao and Dr. Ming Xu of the Department of Cardiothoracic Surgery for their valuable comments.

Funding

This study was supported by the National Natural Science Foundation of China (Z.P. 81560131) and Hubei Province Key Projects (Z.P. WJ2017Z008).

Availability of data and materials

All relevant data supporting the conclusions are contained within the article.

Authors’ contributions

ZP designed this study and revised the manuscript. FJ & HX analyzed and interpreted the patient data regarding Behcet’s disease. FJ & ZP conducted the manuscript writing. ZP, FJ & HX treated the patient in the ICU. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written consent was obtained from the patient’s father for the publication of this case report, because the patient was critically ill and her father was authorized to act as her guardian.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.
    Nair JR, Moots RJ. Behcet's disease. Clin Med (Lond). 2017;17(1):71–7.CrossRefGoogle Scholar
  2. 2.
    Bayar S, Unal E, Esen S, Kurt T, Ensari C, Alacayir I. Aortobifemoral graft causing complete intestinal obstruction in a patient with Behcet's disease: report of a case. Surg Today. 2004;34(2):185–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Tuzun H, Seyahi E, Arslan C, Hamuryudan V, Besirli K, Yazici H. Management and prognosis of nonpulmonary large arterial disease in patients with Behcet disease. J Vasc Surg. 2012;55(1):157–63.PubMedCrossRefGoogle Scholar
  4. 4.
    Barnes CG. Treatment of Behcet's syndrome. Rheumatology (Oxford). 2006;45(3):245–7.CrossRefGoogle Scholar
  5. 5.
    Fresko I, Soy M, Hamuryudan V, Yurdakul S, Yavuz S, Tumer Z, Yazici H. Genetic anticipation in Behcet's syndrome. Ann Rheum Dis. 1998;57(1):45–8.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Geri G, Terrier B, Rosenzwajg M, Wechsler B, Touzot M, Seilhean D, Tran TA, Bodaghi B, Musset L, Soumelis V, et al. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease. J Allergy Clin Immunol. 2011;128(3):655–64.PubMedCrossRefGoogle Scholar
  7. 7.
    Touma Z, Farra C, Hamdan A, Shamseddeen W, Uthman I, Hourani H, Arayssi T. TNF polymorphisms in patients with Behcet disease: a meta-analysis. Arch Med Res. 2010;41(2):142–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Bonyadi M, Jahanafrooz Z, Esmaeili M, Kolahi S, Khabazi A, Ebrahimi AA, Hajialilo M, Dastgiri S. TNF-alpha gene polymorphisms in Iranian Azeri Turkish patients with Behcet's disease. Rheumatol Int. 2009;30(2):285–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behcet's disease. Br J Dermatol. 2006;155(2):350–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Kamoun M, Chelbi H, Houman MH, Lacheb J, Hamzaoui K. Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease. Hum Immunol. 2007;68(3):201–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Akman A, Sallakci N, Kacaroglu H, Tosun O, Yavuzer U, Alpsoy E, Yegin O. Relationship between periodontal findings and the TNF-alpha gene 1031T/C polymorphism in Turkish patients with Behcet's disease. J Eur Acad Dermatol Venereol. 2008;22(8):950–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Leng RX, Chen GM, Pan HF, Ye DQ. The role of IL-23/IL-17 axis in the etiopathogenesis of Behcet's disease. Clin Rheumatol. 2010;29(10):1209.PubMedCrossRefGoogle Scholar
  13. 13.
    Ekinci NS, Alpsoy E, Karakas AA, Yilmaz SB, Yegin O. IL-17A has an important role in the acute attacks of Behcet's disease. J Invest Dermatol. 2010;130(8):2136–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Yokota K, Hayashi S, Araki Y, Isogai E, Kotake S, Yoshikawa K, Fujii N, Hirai Y, Oguma K. Characterization of Streptococcus sanguis isolated from patients with Behcet's disease. Microbiol Immunol. 1995;39(9):729–32.PubMedCrossRefGoogle Scholar
  15. 15.
    La Regina M, Orlandini F, Prisco D, Dentali F. Homocysteine in vascular Behcet disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 2010;30(10):2067–74.PubMedCrossRefGoogle Scholar
  16. 16.
    Shanker J, Gasparyan AY, Kitas GD, Kakkar VV. Platelet function and antiplatelet therapy in cardiovascular disease: implications of genetic polymorphisms. Curr Vasc Pharmacol. 2011;9(4):479–89.PubMedCrossRefGoogle Scholar
  17. 17.
    Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47–58.PubMedCrossRefGoogle Scholar
  18. 18.
    Belguendouz H, Messaoudene D, Lahmar K, Ahmedi L, Medjeber O, Hartani D, Lahlou-Boukoffa O, Touil-Boukoffa C. Interferon-gamma and nitric oxide production during Behcet uveitis: immunomodulatory effect of interleukin-10. J Interf Cytokine Res. 2011;31(9):643–51.CrossRefGoogle Scholar
  19. 19.
    Ketari JS, Chaaba H, Ben DB, Boussema F, Kochbati S, Cherif O, Rokbani L. Arterial involvement in Behcet's disease: a series of 7 cases. Tunis Med. 2009;87(9):583–8.Google Scholar
  20. 20.
    Kojima N, Sakano Y, Ohki S, Misawa Y. Rapidly growing aortic arch aneurysm in Behcet's disease. Interact Cardiovasc Thorac Surg. 2011;12(3):502–4.PubMedCrossRefGoogle Scholar
  21. 21.
    Spiliotopoulos K, Yanagawa B, Crean A, Overgaard C, Brister SJ. Surgical management of a left anterior descending pseudoaneurysm related to Behcet's disease. Ann Thorac Surg. 2011;91(3):912–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Rico JV, Pedrajas FG, Gonzalez IC, Segura IR. Urgent endovascular treatment of a ruptured tibioperoneal pseudoaneurysm in Behcet's disease. Ann Vasc Surg. 2011;25(3):311–85.CrossRefGoogle Scholar
  23. 23.
    Ullery BW, Pochettino A, Wang GJ, Jackson BM, Fairman RM, Woo EY. Celiac artery aneurysm repair in Behcet disease complicated by recurrent thoracoabdominal aortic aneurysms. Vasc Endovasc Surg. 2010;44(2):146–9.CrossRefGoogle Scholar
  24. 24.
    Calguneri M, Kiraz S, Ertenli I, Benekli M, Karaarslan Y, Celik I. The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet's disease. A randomized clinical trial. Arthritis Rheum. 1996;39(12):2062–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Kim WH, Choi D, Kim JS, Ko YG, Jang Y, Shim WH. Effectiveness and safety of endovascular aneurysm treatment in patients with vasculo-Behcet disease. J Endovasc Ther. 2009;16(5):631–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Shen C, Li W, Zhang Y, Li Q, Jiao Y, Zhang T, Zhang X. Outcomes of surgery for patients with Behcet's disease causing aortic pseudoaneurysm: a shift from open surgery to endovascular repair. Clinics (Sao Paulo). 2016;71(6):302–10.CrossRefGoogle Scholar
  27. 27.
    Naganuma M, Iwao Y, Inoue N, Hisamatsu T, Imaeda H, Ishii H, Kanai T, Watanabe M, Hibi T. Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet's disease. Am J Gastroenterol. 2000;95(10):2848–51.PubMedGoogle Scholar
  28. 28.
    Kwon TW, Park SJ, Kim HK, Yoon HK, Kim GE, Yu B. Surgical treatment result of abdominal aortic aneurysm in Behcet's disease. Eur J Vasc Endovasc Surg. 2008;35(2):173–80.PubMedCrossRefGoogle Scholar

Copyright information

© The Author(s). 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.Department of Critical Care MedicineZhongnan Hospital of Wuhan UniversityWuhanPeople’s Republic of China

Personalised recommendations